Kamal D. Puri - Concepedia

Author

Kamal D. Puri

Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Also Known As

K D Puri, K Puri, K. D. Puri, K.D. Puri, Kamal D Puri, Kamal D. Puri, Kamal Deep PURI, Kamal Deep Puri, Kamal Puri, Kamal D. Puri

Publications

Citations

H-Index

Concepts

All Affiliations

Dana-Farber/Boston Children's Cancer and Blood Disorders Center EKOS Corporation Gilead Sciences (United States)Queen Mary University of London Harvard University

About

Kamal D. Puri is an author at Dana-Farber/Boston Children's Cancer and Blood Disorders Center specializing in medicine, cell signaling, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	22	2.2K
2	Allergy	5	5	479
3	Natural Sciences	3	3	266
4	Engineering	2	2	96
5	Health Sciences	1	1	19

Kamal D. Puri

Publications

5.9K

Citations

H-Index

Page 1

	Year	Citations
CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability Brian J. Lannutti, Sarah Meadows, Sarah E.M. Herman, Blood	2010	712
Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease James Kinchen, Hannah H. Chen, Kaushal Parikh, Cell	2018	681
Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals Sarah E.M. Herman, Amber Gordon, Amy J. Wagner, Blood	2010	541
The Kinetics of L-selectin Tethers and the Mechanics of Selectin-mediated Rolling R. Alon, Shuqi Chen, Kamal D. Puri, The Journal of Cell Biology	1997	352
Platelet-Mediated Lymphocyte Delivery to High Endothelial Venules Thomas G. Diacovo, Kamal D. Puri, R A Warnock, Science ImmunologyBlood CellBiomedical EngineeringCellular PhysiologyInflammation	1996	304
Inhibition of phosphoinositide 3‐kinase δ attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model Kyung S. Lee, Ho K. Lee, Joel S. Hayflick, The FASEB Journal AsthmaInflammatory Lung DiseaseLung InflammationAllergy MedicineImmunology	2006	246
Regulation of Class-Switch Recombination and Plasma Cell Differentiation by Phosphatidylinositol 3-Kinase Signaling Sidne A. Omori, Matthew H. Cato, Amy Anzelon-Mills, Immunity Signal TransductionDevelopmental BiologyCell DivisionPhosphatidylinositol 3-KinaseCell Regulation	2006	241
Mechanisms and implications of phosphoinositide 3-kinase δ in promoting neutrophil trafficking into inflamed tissue Kamal D. Puri, Teresa A. Doggett, Jason Douangpanya, Blood	2004	198
PI3K/p110δ is a novel therapeutic target in multiple myeloma Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, Blood	2010	186
The role of endothelial PI3Kγ activity in neutrophil trafficking Kamal D. Puri, Teresa A. Doggett, Ching‐Yu Huang, Blood	2005	159

Page 1